Invention Grant
- Patent Title: Halogenated quinazolin-THF-amines as PDE1 inhibitors
-
Application No.: US15301210Application Date: 2015-03-27
-
Publication No.: US10005764B2Publication Date: 2018-06-26
- Inventor: Jan Kehler , Lars Kyhn Rasmussen , Morten Langgård
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: DK201400194 20140404
- International Application: PCT/EP2015/056713 WO 20150327
- International Announcement: WO2015/150254 WO 20151008
- Main IPC: C07D405/12
- IPC: C07D405/12 ; C07D403/12 ; C07D491/048
Abstract:
The present invention provides halogenated quinazolin-THF-amines as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
Public/Granted literature
- US20170022186A1 Halogenated Quinazolin-THF-Amines as PDE1 Inhibitors Public/Granted day:2017-01-26
Information query
